HVC
LAB icon

Healthcare Value Capital’s Standard BioTools LAB Stock Holding History

Healthcare Value Capital’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-100,000
Closed -$504K – 14
2017
Q3 		$504K Sell
100,000
-50,000
-33% -$210K 1.01% 12
2017
Q2 		$606K Buy
150,000
+100,000
+200% +$474K 1.09% 16
2017
Q1 		$285K Buy
+50,000
New +$317K 0.49% 18

Other funds holding LAB

EIP
Easterly Investment Partners Beverly, Massachusetts $1.31B AUM 18.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Healthcare Value Capital's LAB Position: Q1 2019 in Review

Healthcare Value Capital sold out of Standard BioTools (LAB) in Q1 2019, closing a stake of 450,000 shares — an estimated $3.88M sold.

Healthcare Value Capital first reported a position in LAB in Q1 2017 and held it in 8 quarters. The position peaked at $3.88M in Q4 2018. 131 funds tracked by Wall St. Rank hold LAB as of Q1 2019.

  • Healthcare Value Capital reported no remaining Standard BioTools position as of Q1 2019 after selling out during the quarter.
  • Healthcare Value Capital sold 450,000 Standard BioTools shares in Q1 2019, an estimated $3.88M.
  • Healthcare Value Capital first reported a position in Standard BioTools in Q1 2017 and held it in 8 quarters.
  • Healthcare Value Capital's Standard BioTools position peaked at $3.88M in Q4 2018.
  • 131 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2019.

Based on Healthcare Value Capital's 13F filing for Q1 2019, filed 14 May 2019.